These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6752078)

  • 41. Controlled clinical trial of nomifensine, a non tricyclic antidepressant drug.
    De Maio D; Nielsen NP; Sesso M; Griner A
    Acta Neurol (Napoli); 1978; 33(3):230-42. PubMed ID: 371350
    [No Abstract]   [Full Text] [Related]  

  • 42. [Study of nomifensine in the treatment of depressive states (author's transl)].
    Zermatten A; Cumps J
    Acta Psychiatr Belg; 1981; 81(4):379-98. PubMed ID: 7036657
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Double-blind comparison of diclofensine with nomifensine in outpatients with dysphoric mood.
    Funke HJ; Holtmann W; Ismail S; Jansen W; Leonhardt KF; Muth H; Omer LM; O'Connolly M; Ramm H
    Pharmacopsychiatry; 1986 May; 19(3):120-3. PubMed ID: 3725890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differences in effect between nomifensine and nortriptyline.
    Pöldinger W; Gammel G
    Int Pharmacopsychiatry; 1978; 13(1):58-68. PubMed ID: 342438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Four new atypical antidepressants (trazodone, mianserin, nomifensine, caroxazone): results of controlled trials.
    Cassano GB; Conti L; Dell'Osso L; Massimetti G
    Adv Biochem Psychopharmacol; 1982; 32():125-39. PubMed ID: 7046361
    [No Abstract]   [Full Text] [Related]  

  • 46. [Controlled clinical trial of nomifensine in treatment of depression (author's transl)].
    Zaccara G; Ferrara M; Ardito P
    Riv Patol Nerv Ment; 1979; 100(3):111-20. PubMed ID: 400045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Nomifensine: clinical data (author's transl)].
    Clerc G; Cayreyre M
    Nouv Presse Med; 1978 Jun; 7(26):2295-304. PubMed ID: 353720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A multicentre double-blind comparative trial of zimeldine and imipramine in primary major depressive disorders.
    Hiramatsu KI; Takahashi R; Mori A; Inoue R; Kazamatsuri H; Murasaki M; Sakuma A
    Acta Psychiatr Scand Suppl; 1983; 308():41-54. PubMed ID: 6230895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical effects and serum levels of nomifensine in depressive patients.
    Syvälahti E; Lindberg R; Iisalo E
    J Int Med Res; 1983; 11(5):259-62. PubMed ID: 6357888
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Results of the clinical trial with nomifensine (author's transl)].
    Kabes J; Balon R; Papezová H
    Cesk Psychiatr; 1981 Feb; 77(1):42-9. PubMed ID: 7018711
    [No Abstract]   [Full Text] [Related]  

  • 51. Dexamethasone suppression test predicts response to nomifensine or amitriptyline.
    Beckmann H; Holzmüller B; Fleckenstein P
    Br J Psychiatry; 1984 Apr; 144():440-1. PubMed ID: 6722407
    [No Abstract]   [Full Text] [Related]  

  • 52. Do have antidepressants of the second generation anxiolytic properties?
    Kabes J; Dostal T; Balon R
    Agressologie; 1981 Nov; 22(E):11-3. PubMed ID: 7332041
    [No Abstract]   [Full Text] [Related]  

  • 53. Maprotiline versus imipramine and placebo in neurotic depression.
    van der Velde CD
    J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nomifensine: the preclinical and clinical profile of a second generation antidepressant.
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):1-105. PubMed ID: 6370968
    [No Abstract]   [Full Text] [Related]  

  • 55. Dopaminergic agonist nomifensine compared with amitriptyline: a double-blind clinical trial in acute primary depressions.
    Grof P; Saxena B; Daigle L; Mahutte G
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):221S-225S. PubMed ID: 334227
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nomifensine (Merital), a new non-tricyclic antidepressant.
    Med Lett Drugs Ther; 1985 Aug; 27(695):73-4. PubMed ID: 4021924
    [No Abstract]   [Full Text] [Related]  

  • 57. Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.
    McEvoy JP; Libiger J; Wilson WH; Ban TA; Berney S; Guy W
    J Clin Psychiatry; 1982 Mar; 43(3):111-2. PubMed ID: 7037758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A double blind comparison of the efficacy and safety of trazodone and imipramine in endogenous depression.
    Al-Yassiri MM; Ankier SI; Bridges PK
    J Affect Disord; 1983 Nov; 5(4):333-40. PubMed ID: 6229564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of electroconvulsive therapy with imipramine in endogenous depression: a double blind study.
    Gangadhar BN; Kapur RL; Kalyanasundaram S
    Br J Psychiatry; 1982 Oct; 141():367-71. PubMed ID: 6756530
    [No Abstract]   [Full Text] [Related]  

  • 60. Imipramine for treatment of chronic depression.
    Kocsis JH; Frances A; Mann JJ; Sweeney J; Voss C; Mason B; Brown RP
    Psychopharmacol Bull; 1985; 21(3):698-700. PubMed ID: 3898184
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.